Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000162096 | SCV000923560 | uncertain significance | Intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics and Genomics, |
RCV001269525 | SCV001449570 | pathogenic | not provided | 2014-10-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001269525 | SCV002116852 | uncertain significance | not provided | 2022-09-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ANK3 protein function. ClinVar contains an entry for this variant (Variation ID: 162094). This variant has not been reported in the literature in individuals affected with ANK3-related conditions. This variant is present in population databases (rs730882195, gnomAD 0.0009%). This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 968 of the ANK3 protein (p.Asp968His). |
Clinical Genetics and Genomics, |
RCV000162096 | SCV000195550 | likely pathogenic | Intellectual disability-hypotonia-spasticity-sleep disorder syndrome | 2014-11-24 | flagged submission | clinical testing |